Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Checked against the public recordLast updated Oct 8, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- VA Office of Research and Development
- Interventions being studied
- Behavioral: Unsigned note to provider about cessation medication prescription; Behavioral: Proactive Telephone Counseling from VA Quitline
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Providers who schedule patients for a lung cancer screening at either of the two VA sites. * Patients who participate in lung cancer screening and are current smokers at the time of scheduling their screening exam. Exclusion Criteria: * Providers who currently systematically prescribe cessation support medication to all current smokers will be excluded. * Patients with urgent findings requiring biopsy/immediate attention on the screening CT will be excluded. * Patients with a prior diagnosis of lung cancer or who are receiving active therapy for any cancer, except skin cancer, will be excluded. * Patients previously diagnosed with cognitive impairment, dementia, or severe behavioral disorders, or have an indication in chart review of difficulty communicating or participating in telephone counseling sessions will be excluded.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NYNew York, New York
- Providence VA Medical Center, Providence, RIProvidence, Rhode Island
- VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 8, 2024. Always confirm current availability with the study team.